European Metals Holdings Valuation
Is E861 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of E861 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate E861's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate E861's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for E861?
Key metric: As E861 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is E861's PS Ratio? | |
|---|---|
| PS Ratio | 34.6x |
| Sales | AU$868.87k |
| Market Cap | AU$30.08m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 29.3x |
| Enterprise Value/EBITDA | -17.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does E861's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
DLX Delignit | 0.3x | 10.2% | €24.4m |
IBU IBU-tec advanced materials | 0.6x | 19.2% | €30.7m |
BIG1 Bio-Gate | 0.8x | 16.3% | €6.3m |
BNN BRAIN Biotech | 1.3x | 8.5% | €70.8m |
E861 European Metals Holdings | 34.6x | 6.7% | €15.6m |
Price-To-Sales vs Peers: E861 is expensive based on its Price-To-Sales Ratio (34.6x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does E861's PS Ratio compare vs other companies in the European Metals and Mining Industry?
| 35 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 35 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: E861 is expensive based on its Price-To-Sales Ratio (34.6x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is E861's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 34.6x |
| Fair PS Ratio | 5.5x |
Price-To-Sales vs Fair Ratio: E861 is expensive based on its Price-To-Sales Ratio (34.6x) compared to the estimated Fair Price-To-Sales Ratio (5.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.88
7D
0.5%
1Y
-16.8%
Tokuyama
JP¥197.6b
Produces and sells various chemical products in Japan.
TBT
JP¥16.70
7D
5.0%
1Y
16.0%
Mitsubishi Chemical Group
JP¥1.2t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥5.27
7D
2.9%
1Y
-8.1%